title: The surgeon's role in immunotherapy.
abstract: Immunotherapy in the multidisciplinary care of the cancer patient will play an increasingly important role in cancer therapy for solid tumors. Strategies to optimize surgical management for an effective immune response against tumors should be acknowledged and promoted by the surgical community. Immunotherapy can serve as a beneficial adjunct to surgical excision for high-risk and recurrent tumors, with the attraction of decreased toxicity and disability over current adjuvant treatment methods. It is important that surgeons recognize immunotherapy's potential and play an active role in developing immunotherapy treatment regimens, for without surgical involvement many of these therapies may never come to fruition. This article reviews the key roles that surgeons play in immunotherapy treatment and research.
authors.affiliation: Department of Surgery, University of North Dakota School of Medicine and Health Sciences, 501 North Columbia Road, Grand Forks, ND 58201, USA. rsticca@medicine.nodak.edu
authors.forename: Robert P
authors.initials: RP
authors.lastname: Sticca
authors.forename: Jonathan A
authors.initials: JA
authors.lastname: Sticca
mesh_terms: D003131:Combined Modality Therapy; D006801:Humans; D007167:Immunotherapy; D008495:Medical Oncology; D009369:Neoplasms / Q000276:immunology / Q000601:surgery* / Q000628:therapy; D010820:Physicians